Printer Friendly

Browse Atopic dermatitis topic

Drug therapy subtopic

Articles

1-117 out of 117 article(s)
Title Author Type Date Words
Aclaris submits IND application for topical 'soft' JAK1/3 inhibitor. Jul 7, 2020 194
AbbVie's Rinvoq meets efficacy endpoints in Phase 3 dermatitis study. Report Jun 18, 2020 246
Fast, aggressive eczema treatment linked to fewer food allergies by age 2 years. Smith, Jennie Jun 1, 2020 514
Fast, aggressive eczema treatment linked to fewer food allergies by age 2 years. Smith, Jennie Jun 1, 2020 513
Regeneron, Sanofi announce FDA approval of Dupixent for children. May 26, 2020 153
LEO Pharma, Oneness Biotech and Microbio Shanghai partnership to develop the drug candidate FB825 for atopic dermatitis and asthma. Apr 15, 2020 236
LEO Pharma, Oneness Biotech and Microbio Shanghai partnership to develop the drug candidate FB825 for atopic dermatitis and asthma. Apr 15, 2020 240
Boragen partners with Animal Health Company for discovery and development of canine atopic dermatitis treatment. Jan 8, 2020 187
US FDA grants Dermira's lebrikizumab fast track designation. Dec 12, 2019 272
US FDA grants Dermira's lebrikizumab fast track designation. Dec 12, 2019 268
Aslan's Rally Grows After Positive Readout From Eczema Drug Study. Shanthi Rexaline Dec 2, 2019 470
Samsung BioLogics to produce drugs for Ichnos Sciences. Nov 5, 2019 589
ONCE-DAILY: JAK inhibitor for atopic dermatitis effective in phase 3 study. Jancin, Bruce Report Nov 1, 2019 886
Treatment of Atopic Dermatitis in Pediatric Patients: Nursing Implications. Kimler, Katelin A.; McDonald, Danielle; Shah, Pooja B. Sep 1, 2019 8133
Sanofi Eczema Drug Approved In Europe For Use In Teenagers. Aug 6, 2019 386
QUALITY OF LIFE MEASUREMENT ALTERATION AMONG VIETNAMESE: IMPACT AND TREATMENT BENEFIT RELATED TO ECZEMA. Report Jun 30, 2019 4551
Regeneron Pharmaceuticals Inc wins US FDA approval for Dupixent to treat moderate-to-severe atopic dermatitis. Mar 13, 2019 282
Regeneron Pharmaceuticals Inc wins US FDA approval for Dupixent to treat moderate-to-severe atopic dermatitis. Mar 13, 2019 278
Sanofi wins US FDA approval for Dupixent to treat adolescent patients with moderate-to-severe atopic dermatitis. Mar 12, 2019 289
Sanofi wins US FDA approval for Dupixent to treat adolescent patients with moderate-to-severe atopic dermatitis. Mar 12, 2019 285
Regeneron, Sanofi announce FDA approval of Dupixent for adolescent dermatitis. Mar 12, 2019 119
Korean Biotech Selects Orgenesis' Subsidiary To Manufacture Dermatitis Treatment In Europe. Mar 4, 2019 265
Korean Biotech Selects Orgenesis' Subsidiary To Manufacture Dermatitis Treatment In Europe. Mar 4, 2019 265
Cream tested in atopic dermatitis. Splete, Heidi Brief article Feb 1, 2019 238
Spherium's Cyclatop (SP14019), Safe and Efficacious for the Treatment of Atopic Dermatitis in Adults and Infants. Sep 15, 2018 890
Doctors Can Help Children, Teens Adhere to Eczema Treatment Plan; Aids include simplifying treatment, creating reminders, sharing success stories. Aug 3, 2018 179
Systemic corticosteroids not recommended for long-term treatment of atopic dermatitis. Lacy, Ian Clinical report Jun 1, 2018 744
Systemic corticosteroids not recommended for long-term treatment of atopic dermatitis. Lacy, Ian Clinical report Jun 1, 2018 743
SCSs not the drugs to use for long-term eczema treatment. Lacy, Ian Mar 1, 2018 436
Regeneron reports approval of Dupixent in Japan for atopic dermatitis. Jan 22, 2018 142
US Food and Drug Administration grants breakthrough therapy designation to AbbVie's upadacitinib (ABT-494). Jan 10, 2018 178
US Food and Drug Administration grants breakthrough therapy designation to AbbVie's upadacitinib (ABT-494). Jan 10, 2018 174
Advanced Effect of Moringa oleifera Bioconversion by Rhizopus oligosporus on the Treatment of Atopic Dermatitis: Preliminary Study. Hur, Sang-sun; Choi, Suk-won; Lee, Dong-ryul; Park, Jong-hwan; Chung, Tae-ho Report Jan 1, 2018 4764
Pfizer Commences Phase 3 Trial of JAK1 Inhibitor for Treatment of Atopic Dermatitis. Clinical report Dec 15, 2017 309
Topical Therapy for Atopic Dermatitis: New and Investigational Agents. Gold, Linda F. Stein; Eichenfield, Lawrence F. Dec 1, 2017 3108
Topical Therapy for Atopic Dermatitis: New and Investigational Agents. Gold, Linda F. Stein; Eichenfield, Lawrence F. Dec 1, 2017 3047
Regeneron and Sanofi wins EU approval for DUPIXENT for the treatment of Atopic Dermatitis. Sep 28, 2017 237
Regeneron and Sanofi wins EU approval for DUPIXENT for the treatment of Atopic Dermatitis. Sep 28, 2017 233
Medimetriks Study Shows Topical PDE4 Inhibitor Provides Early Itch Relief in Patients with Atopic Dermatitis. Sep 7, 2017 279
Ralexar Therapeutics Begins Patient Enrollment for Phase 2b Study of Topical Gel for Treatment of Atopic Dermatitis. Clinical report Jun 2, 2017 353
Nonpharmacologic strategies and topical agents for treating atopic dermatitis: an update. Gold, Linda F. Stein; Eichenfield, Lawrence F. Apr 1, 2017 2387
Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment. Eichenfield, Lawrence F.; Stein Gold, Linda F. Apr 1, 2017 3449
Nonpharmacologic strategies and topical agents for treating Atopic Dermatitis: An update. Stein Gold, Linda F.; Eichenfield, Lawrence F. Apr 1, 2017 2405
Addressing the immunopathogenesis of Atopic Dermatitis: Advances in topical and systemic treatment. Eichenfield, Lawrence F.; Stein Gold, Linda F. Apr 1, 2017 3318
Nonpharmacologic strategies and topical agents for treating atopic dermatitis: an update. Gold, Linda F. Stein; Eichenfield, Lawrence F. Apr 1, 2017 2391
Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment. Eichenfield, Lawrence F.; Gold, Linda F. Stein Apr 1, 2017 3321
Nonpharmacologic strategies and topical agents for treating atopic dermatitis: an update. Gold, Linda F. Stein; Eichenfield, Lawrence F. Apr 1, 2017 2394
Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment. Eichenfield, Lawrence F.; Gold, Linda F. Stein Apr 1, 2017 3752
Sanofi and Regeneron Pharmaceuticals wins US FDA approval for Dupixent Injection for treating atopic dermatitis in adults. Mar 29, 2017 355
Sanofi and Regeneron Pharmaceuticals wins US FDA approval for Dupixent Injection for treating atopic dermatitis in adults. Mar 29, 2017 351
FDA clears eczema treatment from Pfizer. Jan 16, 2017 129
Pfizer wins US FDA approval for EUCRISA ointment 2% for the treatment of mild to moderate atopic dermatitis. Dec 15, 2016 271
Pfizer wins US FDA approval for EUCRISA ointment 2% for the treatment of mild to moderate atopic dermatitis. Dec 15, 2016 267
Spherium Biomed Starts Efficacy Trial Cyclatop for the Treatment of Atopic Dermatitis in Adults and Infants. Sep 29, 2016 768
Assessing the new and emerging treatments for atopic dermatitis. Eichenfield, Lawrence F.; Friedlander, Sheila F.; Simpson, Eric L.; Irvine, Alan D. Aug 1, 2016 4524
New treatment paradigms in atopic dermatitis: understanding and incorporating recent and emerging therapies post-test. Aug 1, 2016 616
Assessing the new and emerging treatments for atopic dermatitis. Eichenfield, Lawrence F.; Friedlander, Sheila F.; Simpson, Eric L.; Irvine, Alan D. Aug 1, 2016 4529
New treatment paradigms in atopic dermatitis: understanding and incorporating recent and emerging therapies post-test. Aug 1, 2016 619
Assessing the new and emerging treatments for atopic dermatitis. Eichenfield, Lawrence F.; Friedlander, Sheila F.; Simpson, Eric L.; Irvine, Alan D. Aug 1, 2016 4340
The FDA has accepted Anacor Pharmaceuticals' New Drug Application (NDA) seeking approval of crisaborole topical ointment, 2%, a non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the potential treatment of mild-to-moderate atopic dermatitis in children and adults. May 1, 2016 143
Non-pharmacological treatment modalities for atopic dermatitis. Todd, G.; Manjra, A.; Sinclair, W.; Levin, M.; Green, R.J. Report Oct 1, 2014 1945
Topical and systemic pharmacological treatment of atopic dermatitis. Puterman, A.; Lewis, H.; Sinclair, W.; Green, R.J. Report Oct 1, 2014 2862
Steroids on dry skin as good as 'soak and smear' in AD. Sep 1, 2014 426
Allerpaws the Only Once-a-Day Personalized Oral Allergy Spray Treatment for Atopic Dermatitis in Dogs and Cats is Now Available in Canada. Jun 27, 2013 258
Pilot study to evaluate the effect of topical dimethicone on clinical signs and skin barrier function in dogs with naturally occurring atopic dermatitis. Pellicoro, C.; Marsella, R.; Ahrens, K. Report Jan 1, 2013 5553
Treatment strategies for atopic dermatitis: optimizing the available therapeutic options. Paller, Amy S.; Simpson, Eric L.; Eichenfield, Lawrence F.; Ellis, Charles N.; Mancini, Anthony J. Oct 1, 2012 6190
The treatment of atopic dermatitis. Fowler, Joseph F., Jr. Jun 1, 2012 3391
-Swedish Meda pays USD420m for Novartis dermatitis drug Elidel. Apr 7, 2011 224
-Swedish Meda pays USD420m for Novartis dermatitis drug Elidel. Apr 7, 2011 225
Topical anti-inflammatory potential of physalin E from Physalis angulata on experimental dermatitis in mice. Pinto, N.B.; Morais, T.C.; Carvalho, K.M.B.; Silva, C.R.; Andrade, G.M.; Brito, G.A.C.; Veras, M.L.; Report Aug 1, 2010 2544
Provectus reports preliminary Phase II data for PH-10 for treatment of psoriasis, atopic dermatitis. Dec 1, 2009 305
Atopy in HIV-infected children in Pretoria. Masekela, R.; Moodley, T.; Mahlaba, N.; Wittenberg, D.F.; Becker, P.; Kitchin, O.; Green, R.J. Clinical report Nov 1, 2009 2951
Pearls help in treatment of teen atopic dermatitis. Splete, Heidi Aug 15, 2007 304
With topical steroids for AD, follow age-specific indications. Jancin, Bruce Aug 1, 2007 681
Atopic dermatitis pipeline promising. Wachter, Jerri Brief article Nov 15, 2006 172
Verdeso foam, dermatop emollient cream. McNamara, Damian Nov 1, 2006 718
Primary care cuts use of calcineurin inhibitors. Jancin, Bruce May 1, 2006 927
Alcohol-free foam good for atopic dermatitis. Jancin, Bruce May 1, 2006 617
New nonsteroidal cream cuts atopic dermatitis relapse risk. Jancin, Bruce Apr 1, 2006 588
Effect on the skin barrier defines efficacy of AD Tx. Walsh, Nancy Jan 1, 2006 709
Topical calcineurin inhibitors can still be used in children. Finn, Robert Oct 15, 2005 467
Improvements in atopic dermatitis attributed to ongoing hypnotherapy. Walsh, Nancy Oct 15, 2005 406
Studies confirm pimecrolimus for atopic dermatitis; treatment reduces flares, need for steroid. Brunk, Doug Sep 1, 2005 589
What is the role of tacrolimus and pimecrolimus in atopic dermatitis? Trammell, Sara; Shakil, Amer; Wilder, Laura Aug 1, 2005 1474
The role of glycyrrhetinic acid in the treatment of atopic dermatitis. Jul 1, 2005 611
Once-daily topical steroid dosing effective for atopic eczema. Green, C.; Colquitt, J.L.; Kirby, J.; Davidson, P. Brief Article Jun 1, 2005 274
Critical elements missing from the management of atopic dermatitis. May 1, 2005 632
Toray, Maruho to co-develop atopic drugs to treat itching. Brief Article Apr 4, 2005 109
Black box recommended for Elidel and protopic. Franklin, Deeanna Mar 15, 2005 1115
Check for infection with frequent atopic dermatitis flares. Boschert, Sherry Mar 15, 2005 586
Tacrolimus, pimecrolimus eyed for off-label use: the drugs are seen as good potential alternatives to mid- to high-potency topical steroids. Jancin, Bruce Feb 1, 2005 642
Pimecrolimus takes the itch out of AD. Mahoney, Diana Feb 1, 2005 492
Study shows tacrolimus better for atopic dermatitis. Bates, Betsy Jan 1, 2005 512
High Th2 cytokine levels may contribute to superinfections in atopic dermatitis. Jancin, Bruce Brief Article Jan 1, 2005 192
Recent advances: combine agents to treat itch in atopic dermatitis. Tucker, Miriam, E. Apr 1, 2004 541
Topical steroids still tops for atopic dermatitis: guidelines from dermatologists. Bates, Betsy Sep 15, 2003 511
Topical treatment of atopic dermatitis with St. John's wort cream--a randomized, placebo controlled, double blind half-side comparison. Schempp, Christoph M.; Windeck, Timo; Hezel, Svea; Simon, Jan C. May 1, 2003 4189
Tacrolimus for atopic dermatitis. (Bottom Line). Jancin, Bruce Feb 1, 2003 373
Tacrolimus for atopic dermatitis. (Bottom Line). Jancin, Bruce Brief Article Dec 15, 2002 367
Drug update: atopic dermatitis. (Rx). Zoler, Mitchel L.; Bates, Betsy Dec 1, 2002 1085
Fexofenadine reduced itching due to atopic dermatitis. (First Placebo-Controlled Trial). Jancin, Bruce Brief Article Oct 15, 2002 273
Tacrolimus effective in large atopic dermatitis study. (Long-Term Safety Shown). Jancin, Bruce Brief Article Aug 1, 2002 269
Topical tacrolimus twice daily is safe for up to 3 years. (Atopic Dermatitis). Zoler, Mitchel L. Brief Article May 1, 2002 239
Elidel for atopic dermatitis works quickly. (Improvements Seen within 8 Days). Kirn, Timothy F. Product/Service Evaluation May 1, 2002 485
FDA grants marketing approval for pimecrolimus. (Promising for Use in Infants). Brunk, Doug Brief Article Feb 1, 2002 580
Macrolide agents: One more effective, one better tolerated. (Pimecrolimus vs. Tacrolimus). Kirn, Timothy F. Brief Article Feb 1, 2002 682
Tacrolimus tackles atopic dermatitis after steroids. (No Rebound, Washout Period). Walsh, Nancy Brief Article Feb 1, 2002 246
Cetirizine delays asthma. (Journal Scan). Splete, Heidi Brief Article Feb 1, 2002 191
FDA okays Elidel for atopic dermatitis in children. (Aged 2 Years and Older). Brunk, Doug Brief Article Jan 1, 2002 565
Nonsteroid Dermatitis Cream Appears Safe, Effective in Trials. MACREADY, NORRA Brief Article Apr 1, 2001 694
Novel Eczema Drug Backed for Approval. MECHCATIE, ELIZABETH Dec 15, 2000 1016
Atopic Dermatitis Tx Safe in Children. BATES, BETSY Brief Article May 1, 2000 650
Waiting for Topical Tacrolimus Approval. GOLDMAN, ERIK L. Brief Article May 1, 2000 451
Tacrolimus Eased Atopic Dermatitis in Adults. BOSCHERT, SHERRY Brief Article May 1, 2000 617
Drug Update: Antibiotics for Atopic Dermatitis. Zoler, Mitchel L.; Mechacatie, Elizabeth Apr 1, 2000 643
Antihistamines for Atopic Dermatitis. Phillips, Robert L. Jr; Koenig, Clint J. Mar 1, 2000 577
Steroid Addiction Often Behind Eyelid Dermatitis. IMPERIO, WINNIE ANNE Brief Article Mar 1, 2000 538

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters